Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CStone receives approval in China to initiate Phase 1 clinical trial for RET inhibitor BLU-667 (CS3009) 2019-03-21 21:32
Adlai Nortye Receives NMPA Approval for Pelareorep (AN1004) in China to Initiate Phase III Clinical Trials 2019-03-21 18:21
Samsung BioLogics Wins 2019 CMO Leadership Awards in All Six Core Categories Three Years in a Row 2019-03-21 13:42
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody 2019-03-21 07:20
WuXi Biologics Receives EMA GMP Certificates 2019-03-20 08:07
I-Mab Biopharma and MorphoSys Announce Initiation of Pivotal Phase 2 Study of TJ202/MOR202 for Multiple Myeloma 2019-03-20 05:05
I-Mab Biopharma Announces Dosing of First Subject in Phase 1 Clinical Trial of Anti-GM-CSF Monoclonal Antibody TJM2 in the United States 2019-03-19 18:00
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD 2019-03-18 23:58
New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Approved for Australian Women(1) 2019-03-18 20:45
Adlai Nortye's Buparlisib (AN2025) Set to Become a Potential Treatment for Anti-PD-1 Non-responding Tumor in HNSCC 2019-03-15 17:06
Clinical Stage Biotech Company InventisBio Inc. Closes $70 Million USD Series C Financing 2019-03-12 07:00
TaiwanJ Pharmaceuticals Obtained US$26M Deal for Licensing and Co-Development Contract with Newsoara Biopharma on JKB-122 Asian Rights 2019-03-09 03:57
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018 2019-03-07 06:00
China Jo-Jo Drugstores Releases 2019 Letter from the Chairman 2019-03-04 21:00
AGC Completes Acquisition of Spanish Synthetic Pharmaceutical Active Ingredient Manufacturer Malgrat Pharma Chemicals 2019-03-04 14:00
CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells from the NMPA 2019-03-01 18:00
CStone Pharmaceuticals listed on the Hong Kong Stock Exchange today 2019-02-27 10:47
China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results 2019-02-25 21:00
Foresee Pharmaceuticals Announces Successful Topline Results from Phase 3 Registration Study of LMIS 25 mg in Prostate Cancer 2019-02-21 18:30
Mallinckrodt Announces Interim Analysis Results for Therakos® Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease 2019-02-21 16:00
1 125 126 127 128 129 158